142 related articles for article (PubMed ID: 3010842)
1. Antiviral activity of 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodocytosine against human cytomegalovirus in human skin fibroblasts.
Colacino JM; Lopez C
Antimicrob Agents Chemother; 1985 Aug; 28(2):252-8. PubMed ID: 3010842
[TBL] [Abstract][Full Text] [Related]
2. Enzymology and pathogenicity in mice of a herpes simplex virus type 1 mutant resistant to 2'-fluoro-2'-deoxy-1-beta-D-arabinofuranosyl-5-iodocytosine.
Colacino J; Brownridge E; Greenberg N; Lopez C
Antimicrob Agents Chemother; 1986 May; 29(5):877-82. PubMed ID: 3015008
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents.
Colacino JM; Lopez C
Antimicrob Agents Chemother; 1983 Oct; 24(4):505-8. PubMed ID: 6316843
[TBL] [Abstract][Full Text] [Related]
4. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
Chou TC; Lopez C; Colacino JM; Feinberg A; Watanabe KA; Fox JJ; Philips FS
Mol Pharmacol; 1984 Nov; 26(3):587-93. PubMed ID: 6092904
[TBL] [Abstract][Full Text] [Related]
5. 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.
Lopez C; Watanabe KA; Fox JJ
Antimicrob Agents Chemother; 1980 May; 17(5):803-6. PubMed ID: 6249196
[TBL] [Abstract][Full Text] [Related]
6. Effects of certain nucleoside analogues on human cytomegalovirus replication in vitro.
Mar EC; Patel PC; Cheng YC; Fox JJ; Watanabe KA; Huang ES
J Gen Virol; 1984 Jan; 65 ( Pt 1)():47-53. PubMed ID: 6319573
[TBL] [Abstract][Full Text] [Related]
7. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific antiviral activity of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) against Marek's disease herpesvirus and turkey herpesvirus.
Schat KA; Schinazi RF; Calnek BW
Antiviral Res; 1984 Oct; 4(5):259-70. PubMed ID: 6097179
[TBL] [Abstract][Full Text] [Related]
9. In vitro metabolism of 1-beta-D-arabinofuranosylcytosine and 1-beta-2'-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells.
Kreis W; Damin L; Colacino J; Lopez C
Biochem Pharmacol; 1982 Mar; 31(5):767-73. PubMed ID: 7082345
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections.
Feinberg A; Leyland-Jones B; Fanucchi MP; Hancock C; Fox JJ; Watanabe KA; Vidal PM; Williams L; Young CW; Philips FS
Antimicrob Agents Chemother; 1985 May; 27(5):733-8. PubMed ID: 2990323
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and purification of the anti-viral agent 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) labeled with iodine-125.
Perlman ME; Conti PS; Schmall B; Watanabe KA
Int J Nucl Med Biol; 1984; 11(3-4):215-8. PubMed ID: 6530342
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of DNA replication in herpes simplex virus infected cells by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine.
Allaudeen HS; Descamps J; Sehgal RK; Fox JJ
J Biol Chem; 1982 Oct; 257(20):11879-82. PubMed ID: 6288702
[No Abstract] [Full Text] [Related]
13. Nucleosides. 139. Synthesis and anticytomegalovirus and antiherpes simplex virus activity of 5'-modified analogues of 2'-fluoroarabinosylpyrimidine nucleosides.
Harada K; Matulic-Adamic J; Price RW; Schinazi RF; Watanabe KA; Fox JJ
J Med Chem; 1987 Jan; 30(1):226-9. PubMed ID: 3027334
[TBL] [Abstract][Full Text] [Related]
14. A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracil.
Suzuki S; Misra HK; Wiebe LI; Knaus EE; Tyrrell DL
Mol Pharmacol; 1987 Mar; 31(3):301-6. PubMed ID: 3031445
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.
Schinazi RF; Peters J; Sokol MK; Nahmias AJ
Antimicrob Agents Chemother; 1983 Jul; 24(1):95-103. PubMed ID: 6625559
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks.
Fourel I; Hantz O; Watanabe KA; Jacquet C; Chomel B; Fox JJ; Trepo C
Antimicrob Agents Chemother; 1990 Mar; 34(3):473-5. PubMed ID: 2334160
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus: inhibition of replication by three new drugs.
Lin JC; Smith MC; Cheng YC; Pagano JS
Science; 1983 Aug; 221(4610):578-9. PubMed ID: 6306771
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of selective inhibition of human cytomegalovirus replication by 1-beta-D-arabinofuranosyl-5-fluorouracil.
Suzuki S; Saneyoshi M; Nakayama C; Nishiyama Y; Yoshida S
Antimicrob Agents Chemother; 1985 Aug; 28(2):326-30. PubMed ID: 3010844
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus.
Lin JC; Smith MC; Pagano JS
Antimicrob Agents Chemother; 1985 Jun; 27(6):971-3. PubMed ID: 2992367
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
